Bagli J - Search Results

1

Identification and synthesis of major metabolites of Vasopressin V2-receptor agonist WAY-151932, and antagonist, Lixivaptan.

Molinari AJ, Trybulski EJ, Bagli J, Croce S, Considine J, Qi J, Ali K, Demaio W, Lihotz L, Cochran D. Molinari AJ, et al. Among authors: bagli j. Bioorg Med Chem Lett. 2007 Nov 1;17(21):5796-800. doi: 10.1016/j.bmcl.2007.08.053. Epub 2007 Aug 28. Bioorg Med Chem Lett. 2007. PMID: 17855087

2

The design, synthesis and physical chemical properties of novel human vasopressin V2-receptor antagonists optimized for parenteral delivery.

Ashwell MA, Bagli JF, Caggiano TJ, Chan PS, Molinari AJ, Palka C, Park CH, Rogers JF, Sherman M, Trybulski EJ, Williams DK. Ashwell MA, et al. Among authors: bagli jf. Bioorg Med Chem Lett. 2000 Apr 17;10(8):783-6. doi: 10.1016/s0960-894x(00)00095-0. Bioorg Med Chem Lett. 2000. PMID: 10782686

3

Metabolites of the angiotensin II antagonist tasosartan: the importance of a second acidic group.

Ellingboe JW, Collini MD, Quagliato D, Chen J, Antane M, Schmid J, Hartupee D, White V, Park CH, Tanikella T, Bagli JF. Ellingboe JW, et al. Among authors: bagli jf. J Med Chem. 1998 Oct 22;41(22):4251-60. doi: 10.1021/jm970690q. J Med Chem. 1998. PMID: 9784100

4

Computer-assisted design and synthesis of novel aldose reductase inhibitors.

Butera J, Bagli J, Doubleday W, Humber L, Treasurywala A, Loughney D, Sestanj K, Millen J, Sredy J. Butera J, et al. Among authors: bagli j. J Med Chem. 1989 Apr;32(4):757-65. doi: 10.1021/jm00124a006. J Med Chem. 1989. PMID: 2539477

5

(Pyrimidinyloxy)acetic acids and pyrimidineacetic acids as a novel class of aldose reductase inhibitors.

Ellingboe J, Alessi T, Millen J, Sredy J, King A, Prusiewicz C, Guzzo F, VanEngen D, Bagli J. Ellingboe J, et al. Among authors: bagli j. J Med Chem. 1990 Oct;33(10):2892-9. doi: 10.1021/jm00172a034. J Med Chem. 1990. PMID: 2120443

6

Antihyperglycemic activity of novel substituted 3H-1,2,3,5-oxathiadiazole 2-oxides.

Ellinboe JW, Alessi TR, Dolak TM, Nguyen TT, Tomer JD, Guzzo F, Bagli JF, McCaleb ML. Ellinboe JW, et al. Among authors: bagli jf. J Med Chem. 1992 Apr 3;35(7):1176-83. doi: 10.1021/jm00085a002. J Med Chem. 1992. PMID: 1560432

7

Antihyperglycemic activity of novel naphthalenyl 3H-1,2,3,5-oxathiadiazole 2-oxides.

Ellingboe JW, Lombardo LJ, Alessi TR, Nguyen TT, Guzzo F, Guinosso CJ, Bullington J, Browne EN, Bagli JF, Wrenn J, et al. Ellingboe JW, et al. Among authors: bagli jf. J Med Chem. 1993 Aug 20;36(17):2485-93. doi: 10.1021/jm00069a006. J Med Chem. 1993. PMID: 8355249

8

Class III antiarrhythmic activity of novel substituted 4-[(methylsulfonyl)amino]benzamides and sulfonamides.

Ellingboe JW, Spinelli W, Winkley MW, Nguyen TT, Parsons RW, Moubarak IF, Kitzen JM, Von Engen D, Bagli JF. Ellingboe JW, et al. Among authors: bagli jf. J Med Chem. 1992 Feb 21;35(4):705-16. doi: 10.1021/jm00082a011. J Med Chem. 1992. PMID: 1542097

9

Synthesis and selective class III antiarrhythmic activity of novel N-heteroaralkyl-substituted 1-(aryloxy)-2-propanolamine and related propylamine derivatives.

Butera JA, Spinelli W, Anantharaman V, Marcopulos N, Parsons RW, Moubarak IF, Cullinan C, Bagli JF. Butera JA, et al. Among authors: bagli jf. J Med Chem. 1991 Nov;34(11):3212-28. doi: 10.1021/jm00115a010. J Med Chem. 1991. PMID: 1956040

10

Troponoids. 7. Chemistry and dopamine agonist activity of ciladopa and related aralkyltroponylpiperazines.

Bagli J, Bogri T, Voith K, Lee D. Bagli J, et al. J Med Chem. 1986 Feb;29(2):186-93. doi: 10.1021/jm00152a004. J Med Chem. 1986. PMID: 3950903

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters